Machina Capital S.A.S. Has $2.41 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Machina Capital S.A.S. decreased its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 19.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,530 shares of the company's stock after selling 3,516 shares during the quarter. Machina Capital S.A.S.'s holdings in Johnson & Johnson were worth $2,410,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. WealthTrak Capital Management LLC purchased a new position in Johnson & Johnson in the 4th quarter valued at approximately $26,000. Conquis Financial LLC purchased a new stake in shares of Johnson & Johnson in the 4th quarter worth about $33,000. Bernard Wealth Management Corp. purchased a new position in Johnson & Johnson during the 4th quarter valued at about $36,000. Highline Wealth Partners LLC raised its position in Johnson & Johnson by 51.8% during the first quarter. Highline Wealth Partners LLC now owns 252 shares of the company's stock worth $42,000 after acquiring an additional 86 shares during the last quarter. Finally, von Borstel & Associates Inc. acquired a new stake in shares of Johnson & Johnson in the first quarter valued at approximately $49,000. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on JNJ. Erste Group Bank upgraded Johnson & Johnson from a "hold" rating to a "buy" rating in a report on Wednesday. Guggenheim reissued a "neutral" rating and issued a $167.00 target price (up previously from $164.00) on shares of Johnson & Johnson in a research note on Thursday, July 17th. Raymond James Financial decreased their price target on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating on the stock in a research note on Monday, April 14th. Wall Street Zen downgraded shares of Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Finally, Morgan Stanley increased their price target on Johnson & Johnson from $171.00 to $176.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 17th. Nine investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Johnson & Johnson currently has an average rating of "Moderate Buy" and an average price target of $174.50.

Johnson & Johnson Stock Down 0.7%

JNJ stock traded down $1.27 during mid-day trading on Friday, hitting $168.29. 6,199,690 shares of the company were exchanged, compared to its average volume of 8,375,731. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.03 and a current ratio of 1.26. The firm has a market cap of $404.92 billion, a P/E ratio of 18.00, a P/E/G ratio of 2.14 and a beta of 0.41. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $169.99. The firm's 50 day simple moving average is $156.08 and its 200 day simple moving average is $155.88.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.09. The firm had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. Johnson & Johnson had a return on equity of 33.07% and a net margin of 25.00%. The business's quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.82 EPS. On average, sell-side analysts predict that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 3.09%. The ex-dividend date is Tuesday, August 26th. Johnson & Johnson's dividend payout ratio (DPR) is 55.61%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.